FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to surgery and can be used when choosing the option of bariatric intervention in obese patients who have non-alcoholic fatty liver disease. For this, the patient's age, body mass index and stage of liver fibrosis are determined in accordance with the FibroTest value. Based on the calculation of the total number of points, a choice is made in favor of restrictive or combined bariatric intervention in subjects with morbid obesity and non-alcoholic fatty liver disease.
EFFECT: method provides a decrease in the incidence of complications from the liver in the postoperative period due to the developed individual selection of surgical intervention, which also allows to reduce the cost of conservative therapy and hospital stay and improve the outcomes of surgery and the quality of life of obese patients with non-alcoholic fatty liver disease.
1 cl, 12 tbl, 10 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
METHOD OF DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN METABOLIC SYNDROME | 2022 |
|
RU2803945C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
METHOD FOR DIAGNOSING HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE WITH TYPE 2 DIABETES MELLITUS | 2019 |
|
RU2732526C1 |
METHOD OF NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MEN | 2023 |
|
RU2803074C1 |
METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2798723C1 |
METHOD FOR VERIFYING CHRONIC HEPATIC PATHOLOGY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2013 |
|
RU2547246C1 |
METHOD FOR DETERMINING A STAGE OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C | 2019 |
|
RU2722877C1 |
Authors
Dates
2021-07-13—Published
2020-07-28—Filed